65,437 trials
Pulmonary Cystic Fibrosis
Primary: Absolute Change in FEV1 % Predicted From Visit 1 to Visit 3 Between ERR-10 Day and ERR-14 Day — 13.30; 13.83 percentage change — p=0.0164
Cancer Diagnosis · Diagnostic Techniques and Procedures · Diagnostic Imaging
Primary: Absolute Accuracy of SUV Max of PET/CT vs PET/MRI — 1.78; 1.08; 0.54; 0.51 ratio
Cutaneous T Cell Lymphoma
Primary: Number of Participants Reported Overall Response (Complete and Partial) of Target Treated Lesions Based on Modified Composite Assessment of Index Lesion Severity…
Convergence Insufficiency · Divergence Insufficiency · Hypertropia
Primary: Number of Participants With Symptom Success at 10 Weeks — 25; 91; 12 Participants
Respiratory Disorders
Primary: Anti-Protein D (PD) Antibody Concentrations, Measured as Component of the NTHi Mcat Investigational Vaccine — 382.7; 511.9; 90.5 EU/mL
Adenocarcinoma
Primary: Overall Survival — 15.7; 9.0 months — p=0.0024
Hidradenitis Suppurativa (HS)
Primary: Number of Patients With Hidradenitis Suppurativa Clinical Response (HiSCR) Determined at Week 16 — 16; 12; 17; 12 Participants
Idiopathic Pulmonary Fibrosis
Primary: Number of Participants With Adverse Events — 0; 0; 2; 3 Participants
Schizophrenia · Schizoaffective Disorder
Primary: Strauss-Carpenter Level of Function Scale — 97.69; 94.56 score on a scale
Coronary Artery Disease
Primary: Change From Baseline Lipid Pool to Follow up as Assessed by NIRS/IVUS With Treatment of Ticagrelor
Non-small Cell Lung Cancer
Primary: Phase Ib: Frequency of Dose Limiting Toxicities (DLTs) — 0; 0; 0; 0 Participants
Neuromuscular Blockade · Anesthesia
Primary: Time in Minutes to Reach Train of Four (TOF) Ratio ≥ 0.9 After the Administration of Reversal Agent — 8; 3 minutes — p=<0.001
Heart Disease
Primary: Number of Patients With Atrial Arrhythmia — 121; 134 Participants — p=0.34
COPD
Primary: Average EPAP During Overnight PSG — 9.5 cmH2O
Advanced Lymphoma · Advanced Malignant Solid Neoplasm · Hematopoietic and Lymphoid Cell Neoplasm
Primary: Overall Response Rate (ORR) — 35.7 percentage of participants